Breast Imaging: Page 45

Road to RSNA 2017: Women's Imaging Preview
By Kate Madden Yee
Scientific sessions in women's imaging at RSNA 2017 will range from classic research on the effectiveness of breast cancer screening to cutting-edge studies on the use of advanced technologies such as deep learning to improve breast cancer detection.
October 30, 2017
2017 11 02 17 42 1107 Road To Rsna 400
Breast MRI neural networks predict recurrence scores
By Kate Madden Yee
Friday, December 1 | 11:20 a.m.-11:30 a.m. | SST01-06 | Room E450BResearchers in New York have found that deep-learning networks can be trained with breast MRI data to predict Oncotype DX recurrence scores.
October 30, 2017
Is DBT being used in the Medicare population?
By Kate Madden Yee
Wednesday, November 29 | 3:00 p.m.-3:10 p.m. | SSM02-01 | Room E451BDigital breast tomosynthesis (DBT) exams represented just under 20% of mammography screening tests in 2015, the first year of Medicare coverage for the technology, according to researchers from Thomas Jefferson University Hospital in Philadelphia.
October 30, 2017
DBT radiation dose varies depending on tissue density
By Kate Madden Yee
Tuesday, November 28 | 3:30 p.m.-3:40 p.m. | SSJ01-04 | Arie Crown TheaterThe radiation dose from digital breast tomosynthesis (DBT) varies depending on tissue density, according to research being presented at this Tuesday afternoon session.
October 30, 2017
Deep learning with breast MRI boosts lesion detection
By Kate Madden Yee
Tuesday, November 28 | 11:20 a.m.-11:30 a.m. | RC315-14 | Arie Crown TheaterA deep-learning method using multiparametric breast MRI improves automated detection and characterization of breast lesions, according to research being presented at this Tuesday morning session.
October 30, 2017
New technique reduces DBT compression
By Kate Madden Yee
Tuesday, November 28 | 10:40 a.m.-10:50 a.m. | SSG14-02 | Room S405ABIn this session, researchers will discuss how a new imaging technique can reduce breast compression for digital breast tomosynthesis (DBT) -- without increasing radiation dose or decreasing image quality.
October 30, 2017
Breast MRI performs well across many risk factors
By Kate Madden Yee
Tuesday, November 28 | 8:50 a.m.-9:00 a.m. | RC315-02 | Arie Crown TheaterScreening breast MRI is an effective tool for women who carry the BRCA mutation and also for those with a history of breast cancer and/or high-risk lesions, according to research being presented Tuesday morning.
October 30, 2017
Do technologists have more recalls for breast US exams?
By Kate Madden Yee
Monday, November 27 | 3:50 p.m.-4:00 p.m. | SSE01-06 | Arie Crown TheaterDo screening breast ultrasound scans performed by technologists in women with dense tissue lead to more recalls? Find out at this Monday afternoon session.
October 30, 2017
Breast ultrasound's cancer detection rate similar to DBT, mammo
By Kate Madden Yee
Monday, November 27 | 3:00 p.m.-3:10 p.m. | SSE01-01 | Arie Crown TheaterScreening breast ultrasound's cancer detection rate in women with dense tissue is comparable to that of screening mammography and digital breast tomosynthesis (DBT), according to a study conducted at Brown University.
October 30, 2017
Most women continue to be screened with mammo alone
By Kate Madden Yee
Monday, November 27 | 12:15 p.m.-12:45 p.m. | BR224-SD-MOA4 | Lakeside, BR Community, Station 4Fewer than 10% of women who underwent breast cancer screening with mammography in 2015 were screened with digital breast tomosynthesis or ultrasound in addition to mammography, according to this poster presentation to be held on Monday afternoon.
October 30, 2017
Breast MRI neural network predicts treatment response
By Kate Madden Yee
Monday, November 27 | 11:50 a.m.-12:00 p.m. | RC215-17 | Arie Crown TheaterIn this session, researchers will discuss how neural networks based on a breast MRI tumor dataset can help clinicians predict patient response to neoadjuvant chemotherapy.
October 30, 2017
DBT's recall rates remain low over time
By Kate Madden Yee
Monday, November 27 | 9:10 a.m.-9:20 a.m. | RC215-04 | Arie Crown TheaterRecall rates for digital breast tomosynthesis (DBT) remain low over time, even if there are initial increases when the technology is first implemented, according to Yale University researchers.
October 30, 2017
Previous Page
Page 45 of 89
Next Page